Results 181 to 190 of about 542,363 (307)

Long‐term outcomes following alternative second‐line oral glucose‐lowering treatments: Results from the real‐world progression in type 2 diabetes mellitus United Kingdom (RAPIDS‐UK) model

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4181-4191, August 2025.
Abstract Aims To compare long‐term complications for people with type 2 diabetes mellitus (T2DM) following second‐line treatment in routine practice with sulphonylureas (SU), dipeptidyl peptidase‐4 inhibitors (DPP4i), or sodium‐glucose co‐transporter‐2 inhibitors (SGLT2i) added to metformin.
Orlagh U. Carroll   +8 more
wiley   +1 more source

Perioperative immunosuppressive therapy and coronary ostial angioplasty for unstable angina with Takayasu arteritis. [PDF]

open access: yesJ Cardiol Cases, 2023
Shimizu T   +9 more
europepmc   +1 more source

Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation [PDF]

open access: green, 1995
Pietro Amedeo Modesti   +6 more
openalex   +1 more source

A 90 g/day low‐carbohydrate diet improved glycemic control without decreasing frailty in older patients with type 2 diabetes: A secondary analysis of a randomized controlled trial

open access: yesJournal of Diabetes Investigation, Volume 16, Issue 8, Page 1398-1408, August 2025.
A 90 g/day low‐carbohydrate diet improved glycemic control with significantly lower waist circumference. After dietary interventions, the proportions of robust, pre‐frailty, and frailty were not statistically significant between the traditional diabetic diet and low‐carbohydrate diet groups.
Yu‐Ting Wang   +7 more
wiley   +1 more source

Managing unstable angina and coronary care beds effectively [PDF]

open access: bronze, 1999
Anne‐Maree Kelly   +3 more
openalex   +1 more source

Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN‐CK GERCOR Phase II Trial

open access: yesLiver International, Volume 45, Issue 8, August 2025.
ABSTRACT Background & Aims Angiogenesis is critical in intrahepatic cholangiocarcinoma (ICC), a highly lethal cancer with limited treatment options. Sunitinib, a multi‐receptor tyrosine kinase inhibitor, has strong antiangiogenic and antitumor effects.
Louis Gros   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy